MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0013554
Nathsons Pharmaceuticals Private Limited
Nathsons Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.88 Cr
▼ 17% YoY
Net profit · FY 2025
₹87,908
Net margin 0.2%
EBITDA · FY 2025
₹29.44 Lakh
EBITDA margin 6%
Authorised capital
₹65 Lakh
Registered with MCA
Paid-up capital
₹34.33 Lakh
Issued & subscribed
Open charges
₹3.73 Cr
Satisfied ₹1.6 Cr
Company age
35 yrs
Est. 1991
Directors on board
2
As per MCA filings
About Nathsons Pharmaceuticals Private Limited
Data last updated:
Nathsons Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 August 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1991PTC045508. Its GSTIN is 07AAACN0316P1ZH (Delhi).
The company has an authorised share capital of ₹65 Lakh and a paid-up capital of ₹34.33 Lakh. It is led by directors Sudhir Kumar Goyal (Managing Director) and Madhu Goyal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5C/9 Ist Floor New Rohtak Road, New Delhi, Delhi, India – 110005.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.88 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹87,908 (net margin 0.2%) and EBITDA of ₹29.44 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹3.73 Cr and satisfied charges of ₹1.6 Cr on record. Court records list 8 cases involving the company, including 1 filed by the company and 7 filed against it; 1 case is pending.
Nathsons Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0013554). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74899DL1991PTC045508
Registration Number 045508
Incorporation Date 29 August 1991
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0013554
Recognitions & Rankings of Nathsons Pharmaceuticals
Contact details
Nathsons Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address5C/9 Ist Floor New Rohtak Road, New Delhi, Delhi, India – 110005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nathsons Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Nathsons Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nathsons Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Nathsons Pharmaceuticals Private Limited, buy the company report.
Financials of Nathsons Pharmaceuticals Private Limited
FY 2025 filings availableNathsons Pharmaceuticals Private Limited reported revenue of ₹4.88 Cr (down 17% YoY) for FY 2025.
Revenue · FY 2025
₹4.88 Cr ▼ 17%
Net profit · FY 2025
₹87,908 margin 0.2%
EBITDA · FY 2025
₹29.44 Lakh margin 6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 13%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 5%
5 years · compounded
▼ 5%
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹87,908 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nathsons Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nathsons Pharmaceuticals Private Limited
Nathsons Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Kumar Goyal | Managing Director | 29 Aug 1991 | 35 Years 1 Months | Current |
| Madhu Goyal | Whole-Time Director | 24 Aug 2007 | 19 Years 1 Months | Current |
Auditor
Nathsons Pharmaceuticals Private Limited is audited by R P NARANG & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R P NARANG & CO | FY 2020 | 001794N |
Shareholding
The shareholding of Nathsons Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nathsons Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.73 Cr
Satisfied charges
₹1.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jul 2025 | 101133658 | Others | ₹3.75 Lakh | Open | |
| 01 Feb 2022 | 100556195 | Others | ₹44 Lakh | Open | |
| 11 Jun 2012 | 10363575 | Bank of Baroda | ₹9 Lakh | Open | |
| 12 May 2012 | 10354030 | Bank of Baroda | ₹3.5 Lakh | Open | |
| 08 Oct 2010 | 10244266 | Bank of Baroda | ₹3 Cr | Open |
To see the full charge records of Nathsons Pharmaceuticals Private Limited, buy the company report.
Total charge records: 12 View all charges
Legal cases
Nathsons Pharmaceuticals Private Limited has 8 court cases on record: 1 filed by Nathsons Pharmaceuticals, 7 filed against it. 1 case is pending and 7 are disposed.
Total cases
8
Filed by the company
1
Filed against the company
7
Pending
1
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 7 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Civil suit | Filed by the company against M/S Fast Sapience Pvt Ltd | Disposed |
| District court, Central, Delhi | Civil suit | Filed against the company by State | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, Central, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, New Delhi, Delhi | Court case (TRAFFIC CHALLAN) | Filed against the company by State | Disposed |
To see the full case history of Nathsons Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nathsons Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nathsons Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACN0316P1ZH | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nathsons Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nathsons Pharmaceuticals Private Limited has 6 board changes on record since 1991: 2 appointments and 4 cessations. The latest: Ravinder Kumar Singhal ceased to be Director on 30 Nov 2008.
AGM
Nathsons Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 3.75 Lakh with Charge ID 101133658 was registered on 16 Jul 2025.
Filing
Nathsons Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 44.00 Lakh with Charge ID 100556195 was registered on 01 Feb 2022.
Charges
A charge with Bank Of Baroda of Rs. 300.00 Lakh registered on 08 Oct 2010 with Charge ID 10244266 was modified on 06 Sep 2013.
Charges
A charge with Bank Of Baroda amounted to Rs. 9.00 Lakh with Charge ID 10363575 was registered on 11 Jun 2012.
Charges
A charge registered on 25 Jan 2012 via Charge ID 10333566 with Bank Of Baroda was fully satisfied on 14 May 2012.
Charges
A charge with Bank Of Baroda amounted to Rs. 3.50 Lakh with Charge ID 10354030 was registered on 12 May 2012.
Charges
A charge with Bank Of Baroda amounted to Rs. 25.00 Lakh with Charge ID 10333566 was registered on 25 Jan 2012.
Charges
A charge registered on 06 Sep 2001 via Charge ID 80061276 with Bank Of Baroda was fully satisfied on 29 Nov 2010.
Charges
A charge registered on 18 Aug 1997 via Charge ID 80061275 with Bank Of Baroda was fully satisfied on 29 Nov 2010.
Charges
A charge registered on 18 Nov 1993 via Charge ID 80061274 with Bank Of Baroda was fully satisfied on 29 Nov 2010.
18 earlier events are in the company report.
Frequently asked questions
Nathsons Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 August 1991 (35+ years old) and is registered under CIN U74899DL1991PTC045508.
Nathsons Pharmaceuticals has 2 current directors:
- Sudhir Kumar Goyal - Managing Director
- Madhu Goyal - Whole-Time Director
The latest financial statements of Nathsons Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nathsons Pharmaceuticals is 07AAACN0316P1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Nathsons Pharmaceuticals is U74899DL1991PTC045508. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nathsons Pharmaceuticals has 8 court cases on record: 1 filed by the company and 7 filed against it. 1 is pending.
Nathsons Pharmaceuticals was incorporated on 29 August 1991, making it 35+ years old. It is registered with the Registrar of Companies, Delhi.
Ravinder Kumar Singhal ceased to be Director on 30 Nov 2008. Madhu Goyal ceased to be Director on 01 Nov 2007. Madhu Goyal was appointed as Whole-Time Director on 24 Aug 2007. Nathsons Pharmaceuticals has 6 board changes on record in total.
Yes, Nathsons Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0013554).
The registered office of Nathsons Pharmaceuticals is at 5C9 Ist Floor New Rohtak Road, New Delhi, Delhi, India – 110005.